These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24871995)

  • 1. Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthridine scaffold.
    Castriconi F; Paolino M; Giuliani G; Anzini M; Campiani G; Mennuni L; Sabatini C; Lanza M; Caselli G; De Rienzo F; Menziani MC; Sbraccia M; Molinari P; Costa T; Cappelli A
    Eur J Med Chem; 2014 Jul; 82():36-46. PubMed ID: 24871995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acidic biphenyl derivatives: synthesis and biological activity of a new series of potent 5-HT(4) receptor antagonists.
    Brudeli B; Andressen KW; Moltzau LR; Nilsen NO; Levy FO; Klaveness J
    Bioorg Med Chem; 2013 Nov; 21(22):7134-45. PubMed ID: 24113240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer's disease: the design of donecopride.
    Rochais C; Lecoutey C; Gaven F; Giannoni P; Hamidouche K; Hedou D; Dubost E; Genest D; Yahiaoui S; Freret T; Bouet V; Dauphin F; Sopkova de Oliveira Santos J; Ballandonne C; Corvaisier S; Malzert-Fréon A; Legay R; Boulouard M; Claeysen S; Dallemagne P
    J Med Chem; 2015 Apr; 58(7):3172-87. PubMed ID: 25793650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New esters of 4-amino-5-chloro-2-methoxybenzoic acid as potent agonists and antagonists for 5-HT4 receptors.
    Yang D; Soulier JL; Sicsic S; Mathé-Allainmat M; Brémont B; Croci T; Cardamone R; Aureggi G; Langlois M
    J Med Chem; 1997 Feb; 40(4):608-21. PubMed ID: 9046352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of TD-8954, a clinical stage 5-HT(4) receptor agonist with gastrointestinal prokinetic properties.
    McKinnell RM; Armstrong SR; Beattie DT; Fatheree PR; Long DD; Marquess DG; Shaw JP; Vickery RG
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4210-5. PubMed ID: 23756062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease.
    Yahiaoui S; Hamidouche K; Ballandonne C; Davis A; de Oliveira Santos JS; Freret T; Boulouard M; Rochais C; Dallemagne P
    Eur J Med Chem; 2016 Oct; 121():283-293. PubMed ID: 27266998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual histamine H3R/serotonin 5-HT4R ligands with antiamnesic properties: pharmacophore-based virtual screening and polypharmacology.
    Lepailleur A; Freret T; Lemaître S; Boulouard M; Dauphin F; Hinschberger A; Dulin F; Lesnard A; Bureau R; Rault S
    J Chem Inf Model; 2014 Jun; 54(6):1773-84. PubMed ID: 24857631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New benzo[h][1,6]naphthyridine and azepino[3,2-c]quinoline derivatives as selective antagonists of 5-HT4 receptors: binding profile and pharmacological characterization.
    Hinschberger A; Butt S; Lelong V; Boulouard M; Dumuis A; Dauphin F; Bureau R; Pfeiffer B; Renard P; Rault S
    J Med Chem; 2003 Jan; 46(1):138-47. PubMed ID: 12502367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation.
    Long DD; Armstrong SR; Beattie DT; Choi SK; Fatheree PR; Gendron RA; Genov D; Goldblum AA; Humphrey PP; Jiang L; Marquess DG; Shaw JP; Smith JA; Turner SD; Vickery RG
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6048-52. PubMed ID: 22959244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel multi target-directed ligands targeting 5-HT
    Lanthier C; Payan H; Liparulo I; Hatat B; Lecoutey C; Since M; Davis A; Bergamini C; Claeysen S; Dallemagne P; Bolognesi ML; Rochais C
    Eur J Med Chem; 2019 Nov; 182():111596. PubMed ID: 31419776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, Structure-Activity Relationships, and Preclinical Evaluation of Heteroaromatic Amides and 1,3,4-Oxadiazole Derivatives as 5-HT
    Nirogi R; Mohammed AR; Shinde AK; Gagginapally SR; Kancharla DM; Middekadi VR; Bogaraju N; Ravella SR; Singh P; Birangal SR; Subramanian R; Palacharla RC; Benade V; Muddana N; Jayarajan P
    J Med Chem; 2018 Jun; 61(11):4993-5008. PubMed ID: 29763304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of specific probes for human 5-HT4 receptor dimerization studies.
    Soulier JL; Russo O; Giner M; Rivail L; Berthouze M; Ongeri S; Maigret B; Fischmeister R; Lezoualc'h F; Sicsic S; Berque-Bestel I
    J Med Chem; 2005 Oct; 48(20):6220-8. PubMed ID: 16190749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and preliminary screening of novel indole-3-methanamines as 5-HT4 receptor ligands.
    Hanna-Elias A; Manallack DT; Berque-Bestel I; Irving HR; Coupar IM; Iskander MN
    Eur J Med Chem; 2009 Jul; 44(7):2952-9. PubMed ID: 19223092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and SAR of N-(1-((substituted piperidin-4-yl)methyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide derivatives: 5-Hydroxytryptamine receptor 4 agonist as a potent prokinetic agent.
    Park JS; Im W; Choi S; Park SJ; Jung JM; Baek KS; Son HP; Sharma S; Kim IS; Jung YH
    Eur J Med Chem; 2016 Feb; 109():75-88. PubMed ID: 26761776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HT
    Nirogi R; Mohammed AR; Shinde AK; Gagginapally SR; Kancharla DM; Ravella SR; Bogaraju N; Middekadi VR; Subramanian R; Palacharla RC; Benade V; Muddana N; Abraham R; Medapati RB; Thentu JB; Mekala VR; Petlu S; Lingavarapu BB; Yarra S; Kagita N; Goyal VK; Pandey SK; Jasti V
    J Med Chem; 2021 Aug; 64(15):10641-10665. PubMed ID: 34251799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arylcarbamate derivatives of 1-piperidineethanol as potent ligands for 5-HT4 receptors.
    Soulier JL; Yang D; Brémont B; Croci T; Guzzi U; Langlois M
    J Med Chem; 1997 May; 40(11):1755-61. PubMed ID: 9171886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonclinical Cardiovascular Studies of Prucalopride, a Highly Selective 5-Hydroxytryptamine 4 Receptor Agonist.
    Conlon K; De Maeyer JH; Bruce C; Schuurkes JAJ; Christie L; McRedmond J; Derakhchan K; Wade PR
    J Pharmacol Exp Ther; 2018 Feb; 364(2):156-169. PubMed ID: 29180358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists.
    Brudeli B; Moltzau LR; Andressen KW; Krobert KA; Klaveness J; Levy FO
    Bioorg Med Chem; 2010 Dec; 18(24):8600-13. PubMed ID: 21075638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and receptor binding of new thieno[2,3-d]-pyrimidines as selective ligands of 5-HT(3) receptors.
    Modica MN; Romeo G; Salerno L; Pittalà V; Siracusa MA; Mereghetti I; Cagnotto A; Mennini T; Gáspár R; Gál A; Falkay G; Palkó M; Maksay G; Fülöp F
    Arch Pharm (Weinheim); 2008 Jun; 341(6):333-43. PubMed ID: 18535994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of a pharmacophore model for 5-HT4 agonists using CoMFA and receptor based alignment.
    Iskander MN; Leung LM; Buley T; Ayad F; Di Iulio J; Tan YY; Coupar IM
    Eur J Med Chem; 2006 Jan; 41(1):16-26. PubMed ID: 16293350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.